Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry.

Follis KE, York J, Nunberg JH.

Virology. 2006 Jul 5;350(2):358-69. Epub 2006 Mar 7.

3.

Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus.

Migliaccio CT, Follis KE, Matsuura Y, Nunberg JH.

Virus Res. 2004 Sep 15;105(1):47-57.

PMID:
15325080
5.

Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.

York J, Follis KE, Trahey M, Nyambi PN, Zolla-Pazner S, Nunberg JH.

J Virol. 2001 Mar;75(6):2741-52.

6.

Post-exposure chemoprophylaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection.

Tsai CC, Emau P, Sun JC, Beck TW, Tran CA, Follis KE, Bischofberger N, Morton WR.

J Med Primatol. 2000 Aug;29(3-4):248-58.

PMID:
11085587
7.

Turning a corner on HIV neutralization?

Nunberg JH, Follis KE, Trahey M, LaCasse RA.

Microbes Infect. 2000 Feb;2(2):213-21. Review.

PMID:
10742693
8.

Fusion-competent vaccines: broad neutralization of primary isolates of HIV.

LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH.

Science. 1999 Jan 15;283(5400):357-62. Retraction in: Nunberg JH. Science. 2002 May 10;296(5570):1025.

9.
11.

Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity.

LaCasse RA, Follis KE, Moudgil T, Trahey M, Binley JM, Planelles V, Zolla-Pazner S, Nunberg JH.

J Virol. 1998 Mar;72(3):2491-5.

12.

Effects of (R)-9-(2-phosphonylmethoxypropyl)adenine monotherapy on chronic SIV infection in macaques.

Tsai CC, Follis KE, Beck TW, Sabo A, Bischofberger N, Dailey PJ.

AIDS Res Hum Retroviruses. 1997 May 20;13(8):707-12.

PMID:
9168239
13.

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.

Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE, Black R.

Science. 1995 Nov 17;270(5239):1197-9.

PMID:
7502044
14.

Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques.

Tsai CC, Follis KE, Sabo A, Grant R, Bischofberger N.

J Infect Dis. 1995 May;171(5):1338-43. Erratum in: J Infect Dis 1996 Jan;173(1):277.

PMID:
7538551
15.

Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaques.

Tsai CC, Follis KE, Sabo A, Grant RF, Bartz C, Nolte RE, Benveniste RE, Bischofberger N.

J Infect Dis. 1994 Feb;169(2):260-6.

PMID:
8106760
16.

Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques.

Tsai CC, Follis KE, Grant R, Sabo A, Nolte R, Bartz C, Bischofberger N, Benveniste R.

J Med Primatol. 1994 Feb-May;23(2-3):175-83.

PMID:
7966233
17.

Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.

Tsai CC, Follis KE, Grant RF, Nolte RE, Bartz CR, Benveniste RE, Sager PR.

J Acquir Immune Defic Syndr. 1993 Oct;6(10):1086-92.

PMID:
8410666
18.
19.

In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV).

Tsai CC, Follis KE, Yarnall M, Deaver LE, Benveniste RE, Sager PR.

Antiviral Res. 1990 Aug;14(2):87-98.

PMID:
1703397
20.

Maternal transmission of type D simian retrovirus (SRV-2) in pigtailed macaques.

Tsai CC, Follis KE, Snyder K, Windsor S, Thouless ME, Kuller L, Morton WR.

J Med Primatol. 1990;19(3-4):203-16.

PMID:
2172540
21.

Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Tsai CC, Follis KE, Yarnall M, Blakley GA.

Antimicrob Agents Chemother. 1989 Nov;33(11):1908-14.

22.

Antigen capture assay for detection of simian type D retroviruses in cell cultures and plasma samples.

Tsai CC, Yarnall M, Follis KE, Benveniste RE.

Lab Anim Sci. 1989 Nov;39(6):554-9.

PMID:
2480476
23.

Monoclonal antibodies to type D retrovirus (SRV-2).

Tsai CC, Tsai CC, Sligh JM, Yarnall M, Follis KE, Roodman ST.

J Med Primatol. 1989;18(3-4):175-83.

PMID:
2547955

Supplemental Content

Loading ...
Support Center